Bisschops et al., 2017 - Google Patents
Two mutually enabling trends: Continuous bioprocessing and single‐use technologiesBisschops et al., 2017
- Document ID
- 5513152210027506909
- Author
- Bisschops M
- Schofield M
- Grace J
- Publication year
- Publication venue
- Continuous biomanufacturing—Innovative technologies and methods
External Links
- 238000010364 biochemical engineering 0 title description 54
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M47/00—Means for after-treatment of the produced biomass or of the fermentation or metabolic products, e.g. storage of biomass
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
- C12M29/00—Means for introduction, extraction or recirculation of materials, e.g. pumps
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6676073B2 (en) | Continuous elution of products from chromatography columns | |
| Klutz et al. | Developing the biofacility of the future based on continuous processing and single-use technology | |
| Zydney | New developments in membranes for bioprocessing–A review | |
| Gronemeyer et al. | Trends in upstream and downstream process development for antibody manufacturing | |
| Jacquemart et al. | A single-use strategy to enable manufacturing of affordable biologics | |
| US20130115588A1 (en) | Integrated bioreactor and separation system and methods of use therof | |
| Kalyanpur | Downstream processing in the biotechnology industry | |
| Gerstweiler et al. | Continuous downstream bioprocessing for intensified manufacture of biopharmaceuticals and antibodies | |
| US10494421B2 (en) | System, apparatus and method for biomolecules production | |
| JP2018046822A (en) | Continuous processing methods for biological products | |
| Patil et al. | Continuous manufacturing of recombinant therapeutic proteins: upstream and downstream technologies | |
| CN111770986A (en) | System and method for preparing biomolecules (e.g., viral vaccines) | |
| Schwarz et al. | Integrated continuous biomanufacturing on pilot scale for acid‐sensitive monoclonal antibodies | |
| Allison et al. | Current status and future trends for disposable technology in the biopharmaceutical industry | |
| CN113785045A (en) | Facility and method for producing biotherapeutic agents | |
| Bisschops et al. | Two mutually enabling trends: Continuous bioprocessing and single‐use technologies | |
| Gottschalk | Disposables in downstream processing | |
| Minow et al. | Implementing a fully disposable mAb manufacturing facility | |
| Jungbauer et al. | Integrated continuous manufacturing of biopharmaceuticals | |
| JP2024020456A (en) | Integrated and continuous recombinant protein manufacturing | |
| Bisschops | BioSMB technology as an enabler for a fully continuous disposable biomanufacturing platform | |
| Kovács et al. | Diafiltration | |
| Anicetti | Biopharmaceutical processes: a glance into the 21st century | |
| Whitford | Single‐use systems support continuous bioprocessing by perfusion culture | |
| DiBlasi et al. | Disposable biopharmaceutical processes-myth or reality? |